Metabotropic Glutamate Subtype 5 Receptors Are Quantified in the Human Brain With a Novel Radioligand for PET

Journal of Nuclear Medicine - China
doi 10.2967/jnumed.108.056291
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Society of Nuclear Medicine

Related search

Ketamine and Ceftriaxone-Induced Alterations in Glutamate Levels Do Not Impact the Specific Binding of Metabotropic Glutamate Receptor Subtype 5 Radioligand [18F]PSS232 in the Rat Brain

Pharmaceuticals
Molecular MedicinePharmaceutical Science
2018English

Targeting Metabotropic Glutamate Receptors for Novel Treatments of Schizophrenia

Molecular Brain
Molecular NeuroscienceMolecular BiologyCellular
2017English

18f-Fpeb, a PET Radiopharmaceutical for Quantifying Metabotropic Glutamate 5 Receptors: A First-In-Human Study of Radiochemical Safety, Biokinetics, and Radiation Dosimetry

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2013English

A Human PET Study of [11C]HMS011, a Potential Radioligand for AMPA Receptors

EJNMMI Research
Nuclear MedicineRadiologyImaging
2017English

Metabotropic Glutamate Receptor Subtype 4 (mGluR4)

Science-Business eXchange
2010English

Metabotropic Glutamate Receptors for Parkinson's Disease Therapy

Parkinson's Disease
PsychiatryNeuroscienceMental HealthNeurology
2013English

The Metabotropic Glutamate Receptor Subtype 5 Mediates Sensitivity to the Sedative Properties of Ethanol

Pharmacogenetics and Genomics
Molecular MedicineGeneticsMolecular Biology
2010English

Circadian Variation of Metabotropic Glutamate Receptor 5 Availability in the Rat Brain

Journal of Sleep Research
MedicineBehavioral NeuroscienceCognitive Neuroscience
2016English

Imaging of Metabotropic Glutamate Receptors (mGluRs)

2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy